Novel Resistance Mechanisms to Osimertinib Analysed by Whole-Exome Sequencing in Non-Small Cell Lung Cancer

Novel Resistance Mechanisms to Osimertinib Analysed by Whole-Exome Sequencing in Non-Small Cell Lung Cancer

Zhen Wu,1 Wei Zhao,1 Zhen Yang,1 Yue Ming Wang,2 Yu Dai,1 Liang-An Chen1,2 1Respiratory Department of Chinese PLA General Hospital, Beijing, People’s Republic of China; 2School of Medicine, Nankai University, Tianjin, People’s Republic of ChinaCorrespondence: Liang-An Chen IMB 16...

Full description

Bibliographic Details
Main Authors: Wu Z, Zhao W, Yang Z, Wang YM, Dai Y, Chen LA
Format: Article
Language:English
Published: Dove Medical Press 2021-02-01
Series:Cancer Management and Research
Subjects:
osimertinib
drug resistance
whole exome sequencing
lung cancer
targeted therapy.
Online Access:https://www.dovepress.com/novel-resistance-mechanisms-to-osimertinib-analysed-by-whole-exome-seq-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/novel-resistance-mechanisms-to-osimertinib-analysed-by-whole-exome-seq-peer-reviewed-article-CMAR

Similar Items